Epsilogen
1 follower
‌
Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life.
Industries
Headquarters
Employees
Links
Org chart
Tim Wilson
CEO
Tim Wilson
Collapse
Kevin Fitzgerald
Chief Scientific Officer
Nick Robbins-Cherry
Chief Financial Officer
José Iglesias
Chief Medical Officer
Leanne Partington
VP of Product Development
Andrew Calam
Vice President Clinical Operations
